Skip to main content
Log in

Altered responsiveness to endothelin-1 of myocardium from pacing-induced heart failure model in the dog

  • Experimental Pharmacology
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

In congestive heart failure, in addition to a compensatory increase in neurohumoral activation, there is an increase in the endothelial-derived vasoconstrictive and positive inotropic substance, endothelin. Whether downregulation of the cardiac inotropic effects of this endothelial-derived substance occurs, as has been shown to occur with neurohumoral beta- and alpha-adrenergic agonists, remains unknown. In this study we investigated the effects of endothelin-1 [dose-response curve (10-11 to 10-7 M)] on the contractile characteristics of isolated papillary muscles from normal dogs and from dogs with heart failure induced by pacing overdrive, with or without removing endocardial endothelium from the papillary muscles. Endothelin-1 caused a similar absolute increase in myocardial contractile indices in all four groups, except for shortening, which increased more in muscles with heart failure without endocardial endothelium. However, in muscles with an intact endocardial endothelium, the relative increase was greater in muscles from pacing overdrive dogs (failing) as compared with normal dogs (tension increase of 110% vs. 53%, p<0.01 and shortening increase of 127% vs. 24%, p<0.01). Also, failing muscles with intact endocardial endothelium began responding to endothelin-1 at lower endothelin-1 concentrations (10-10 vs. 10-9 M) than normal muscles with intact endocardial endothelium. Endocardial endothelial removal increased the contractile effects of endothelin-1, whether this was done in normal or failing myocardium. This study thus indicates that, in contrast to other positive inotropic substances, in this model of heart failure there is an increase in sensitivity and relative response to endothelin-1. It also indicates that although endocardial endothelial removal increases the relative effects of endothelin-1 in both normal and failing myocardium, the increased responsiveness of failing myocardium is not endocardial endothelial dependent.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bristow M, Ginsburg R, Minobe W, et al. Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing hearts.N Engl J Med 1982;307:205–211.

    PubMed  Google Scholar 

  2. Bristow MR, Minok W, Ramussen R, Hershberger RE, Hoffman B. Alpha-1-adrenergic receptors in the nonfailing and failing human heart.J Pharmacol Exp Ther 1988;247:1039–1045.

    PubMed  Google Scholar 

  3. Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as guide to prognosis in patients with chronic congestive heart failure.N Engl J Med 1984;311:819–823.

    PubMed  Google Scholar 

  4. Rouleau JL, Kortas C, Bichet D, de Champlain J. Neurohumoral and hemodynamic changes in congestive heart failure: Lack of correlation and evidence for compensatory mechanisms.Am Heart J 1988;116:746–757.

    PubMed  Google Scholar 

  5. Vatner DE, Vatner SF, Fuju AM, Homcy CJ. Loss of high affinity cardiac β-adrenergic receptors in dogs with heart failure.J Clin Invest 1985;76:2259–2264.

    PubMed  Google Scholar 

  6. Calderone A, Bouvier M, Li K, Juneau C, Champlain J, Rouleau JL. Dysfunction of the beta- and alpha-adrenergic system in a model of congestive heart failure: Pacing-overdrive dog.Circ Res 1991;69:332–343.

    PubMed  Google Scholar 

  7. Li K, Rouleau JL, Calderone A, L. Andries L, Brutsaert DL. Endocardial dysfunction in pacing-induced heart failure in the dog.J Mol Cell Cardiol 1993;25:529–540.

    PubMed  Google Scholar 

  8. Li K, Stewart DJ, Rouleau JL. Myocardial contractile actions of endothelin-1 in rat and rabbit papillary muscles: Role of endocardial endothelium.Circ Res 1991;69:301–312.

    PubMed  Google Scholar 

  9. McLeod JD, Piper PJ. Effect of removing the endothelium on the vascular responses induced by leukotrienes C4 and D4 in guinea-pig isolated heart.Eur J Pharmacol 1992;212: 67–72.

    PubMed  Google Scholar 

  10. Shah AM, Meulemans AL, Brutsaert DL. Myocardial inotropic responses to aggregating platelet and modulation by the endocardium.Circulation 1989;79:1315–1323.

    PubMed  Google Scholar 

  11. Shah AM, Andries LJ, Meulemans AL, Brutsaert DL. Endocardium modulates myocardial inotropic response to 5-hydroxytryptamine.Am J Physiol 1989257:H1790-H1797.

    PubMed  Google Scholar 

  12. Stewart DJ. Endothelin in cardiopulmonary disease: Factor paracrine vs. neurohumoral.Eur Heart J 1994;14(Suppl I): 48–54.

    Google Scholar 

  13. Wei CM, Lerman A, Rodeheffer RJ, et al. Endothelin in human congestive heart failure.Circulation 1994;89:1580–1586.

    PubMed  Google Scholar 

  14. Calderone A, Rouleau JL, de Champlain J, Belichard P, Stewart DJ. Regulation of the endothelin-1 transmembrane signaling pathway: The potential role of agonist-induced desensitization in the coronary artery of the rapid ventricular pacing-overdrive dog model of heart failure.J Mol Cell Cardiol 1993;25:895–903.

    PubMed  Google Scholar 

  15. Rouleau JL, Paradis P, Shenasa H, Juneau C. Faster time to peak tension and velocity in right versus left ventricular trabeculae and papillary muscles of dogs.Circ Res 1986;59: 556–561.

    PubMed  Google Scholar 

  16. Brutsaert DL, Claes VA, Goethals MA. Effect of calcium on force-velocity-length relations of heart muscle of the cat.Circ Res 1973;32:385–392.

    PubMed  Google Scholar 

  17. Li K, Rouleau JL, Andries LJ, Brutsaert DL. Effect of dysfunctional vascular endothelium on myocardial performance in isolated papillary muscles.Circ Res 1993;72:768–77.

    PubMed  Google Scholar 

  18. Haendler B, Hechler, Schlenning WD. Molecular cloning of human endothelin (ET) receptors ETA and ETB.J Cardiovasc Pharmacol 1992;20(Suppl 12):S1-S4.

    Google Scholar 

  19. Sakurai T, Yanagisawa M, Masaki T. Molecular characterization of endothelin receptors.Trends Pharmacol Sci 1992; 13:103–108.

    PubMed  Google Scholar 

  20. Brady AJB, Poole-Wilson PA, Harding SE, Warren JB. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia.Am J Physiol 1992;263: H1963-H1966.

    Google Scholar 

  21. Kaiser L, Spickard RD, Olivier NB. Heart failure depresses endothelium-dependent responses in canine femoral artery.Am J Physiol 1989;256:H962-H967.

    Google Scholar 

  22. Katz SD, Schwartz M, Yuen J, LeJemtel TH. Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors.Circulation 1993;88:55–61.

    PubMed  Google Scholar 

  23. Juneau C, Calderone A, Rouleau JL. Myocardial β- adrenergic and mechanical properties in pacing-induced heart failure in dogs.Am J Physiol 1992;262:H1458-H1467.

    PubMed  Google Scholar 

  24. Wang J, Paik G, Morgan JP. Endothelin-1 enhances myofilament Ca2+ responsiveness in aequorin-loaded ferret myocardium.Circ Res 1991;69:582–589.

    PubMed  Google Scholar 

  25. Wang J, Morgan JP. Endothelin reverses the effects of acidosis on the intracellular Ca2+ transient and contractility in ferret myocardium.Circ Res 1992;71:631–639.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, K., Rouleau, J.L. Altered responsiveness to endothelin-1 of myocardium from pacing-induced heart failure model in the dog. Cardiovasc Drug Ther 10, 107–112 (1996). https://doi.org/10.1007/BF00823587

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00823587

Key words

Navigation